The objective of this study is to evaluate the willingness of patients with ovarian cancer to undergo genetic testing, given the cost, their understanding and acceptance of genetic testing and the possibility of targeted therapy.
All eligible patients being seen in the Gynecology Center at the M.D. Anderson Cancer Center and at Gynecologic Oncology of Houston for follow-up or a new diagnosis of ovarian cancer will be asked to participate in this study by completing a questionnaire. This study will end when 400 completed questionnaires have been collected. We estimate that 40-60 ovarian cancer patients are seen in the Gynecology Center at the M.D. Anderson Cancer Center each week and that 20- 40 ovarian cancer patients are seen at Gynecologic Oncology of Houston each week. The completion of 400 questionnaires will provide adequate data to address our question in an expeditious time frame. The initial phase of this study is exploratory and does not involve a comparison group.
Study Type
OBSERVATIONAL
Enrollment
237
A questionnaire will be completed.
U.T.M.D. Anderson Cancer Center
Houston, Texas, United States
Participants' Response to Survey Questions (Yes/No)
Time frame: 15-20 minutes to complete survey
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.